Komori
Brains Technology (4075) · InitiativeRestatedLatest General Meetings of Shareholders (2026-10-07): "Advanced"

Creation of New Products and Services Through R&D

First written in FY2021. 11 of 16 entries say "Restated". Latest entry: 2026-10-07.

16entries
6years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2021 – FY2022-Q3RestatedFY2023-Q1 – FY2024-Q3RestatedFY2025-H1 – FY2026-H12021: 22022: 420222023: 320232024: 320242025: 120252026: 32026
Same theme, other companies
Continuation of R&D activities with no change in statusA theme 192 companies write about · 0 as a headwind · 181 as a tailwind

45 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 192 companies compared. The sentences above are computed from all 192.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1RestatedAnnual report

    「The amount spent on our R&D activities during the six-month interim accounting period was ¥40.629 million. There were no material changes in the status of our R&D activities during the six-month interim accounting period.」

    The company continued its R&D activities and recorded R&D expenses of ¥40.629 million. The company itself stated that there were no material changes in the status of its R&D activities during the six-month interim accounting period.
  2. FY2025-H1RestatedAnnual report

    「The amount spent on our R&D activities during the six-month interim accounting period was ¥38.745 million. There were no material changes in the status of our R&D activities during the six-month interim accounting period.」

    The company continued its R&D activities and recorded R&D expenses of ¥38.745 million. The company itself stated that there were no material changes in the status of its R&D activities.
  3. FY2024AdvancedAnnual report

    「The company's R&D activities for the fiscal year were as follows. (1) For the anomaly detection solution Impulse, the company conducted infrastructure technology verification and research and verification of an automated model operation function to ensure stable system operation. It also developed a prototype of a fitting inspection application and verified technology for linking it with sensor devices. (2) For the in-house search engine Neuron Enterprise Search, the company conducted technical research to improve search accuracy. (3) For the generative AI knowledge chat service ChatEI, the company conducted a literature review comparing the performance of large language models and researched methods for verifying accuracy. It also researched and conducted prototype verification of an Agent function, which autonomously uses tools to solve problems according to the circumstances.」

    The company recorded R&D expenses of ¥38.836 million and conducted specific research and prototype verification relating to Impulse's automated model operation, fitting inspection and sensor integration, Neuron's improved search accuracy, and ChatEI's large language models and Agent function.
  4. FY2024-Q3RestatedAnnual report

    「The amount spent on our R&D activities during the cumulative third quarter was ¥26.451 million. There were no material changes in the status of our R&D activities during the cumulative third quarter.」

    The company continued its R&D activities and recorded R&D expenses of ¥26.451 million for the cumulative third quarter. The company itself stated that there were no material changes in the status of its R&D activities.
  5. FY2024-Q2RestatedAnnual report

    「The amount spent on our R&D activities during the cumulative second quarter was ¥16.994 million. There were no material changes in the status of our R&D activities during the cumulative second quarter.」

    The company continued its R&D activities and recorded R&D expenses of ¥16.994 million for the cumulative second quarter. The company itself stated that there were no material changes in the status of its R&D activities.
  6. FY2024-Q1RestatedAnnual report

    「The amount spent on our R&D activities during the cumulative first quarter was ¥8.613 million. There were no material changes in the status of our R&D activities during the cumulative first quarter.」

    The company continued its R&D activities and recorded R&D expenses of ¥8.613 million for the cumulative first quarter. The company itself stated that there were no material changes in the status of its R&D activities.
  7. FY2023-Q3RestatedAnnual report

    「The amount spent on our R&D activities during the cumulative third quarter was ¥57.882 million. There were no material changes in the status of our R&D activities during the cumulative third quarter.」

    The company continued its R&D activities and recorded cumulative R&D expenses of ¥57.882 million. The company itself stated that there were no material changes in the status of its R&D activities.
  8. FY2023-Q2RestatedAnnual report

    「The amount spent on our R&D activities during the cumulative second quarter was ¥43.595 million. There were no material changes in the status of our R&D activities during the cumulative second quarter.」

    The company continued its R&D activities and recorded R&D expenses of ¥43.595 million for the cumulative second quarter. It stated that there were no material changes in the status of these activities.
  9. FY2023-Q1RestatedAnnual report

    「The amount spent on our R&D activities during the cumulative first quarter was ¥22.687 million. There were no material changes in the status of our R&D activities during the cumulative first quarter.」

    The company continued its R&D activities and recorded R&D expenses of ¥22.687 million for the cumulative first quarter. It stated that there were no material changes in the status of these activities.
  10. FY2022AdvancedAnnual report

    「Total R&D expenses for the fiscal year were ¥105.673 million.」

    For Impulse, the company researched and tested machine-learning technologies and algorithms for analyzing work efficiency, workload and quality from video, focusing on improving their accuracy, speed and efficiency. For Neuron, it researched differentiated functions, including improved search accuracy, document classification, text inference and knowledge graphs.
  11. FY2022-Q3RestatedAnnual report

    「The amount spent on our R&D activities during the cumulative third quarter was ¥85.039 million. There were no material changes in the status of our R&D activities during the cumulative third quarter.」

    The company continued its R&D activities and recorded cumulative R&D expenses of ¥85.039 million. It stated that there were no material changes in the status of these activities.
  12. FY2022-Q2RestatedAnnual report

    「The amount spent on our R&D activities during the cumulative second quarter was ¥54.086 million. There were no material changes in the status of our R&D activities during the cumulative second quarter.」

    The company continued its R&D activities and recorded R&D expenses of ¥54.086 million for the cumulative second quarter. It stated that there were no material changes in the status of these activities.
  13. FY2022-Q1RestatedAnnual report

    「We also continued to focus on research and development and enhancing software functionality, as in the previous fiscal year.」

    The company continued its R&D activities and reported R&D expenses of ¥27.271 million for the cumulative first quarter.
  14. FY2021First statedAnnual report

    「We will pursue our growth strategy by continuing to promote our two software packages and creating new products and services through research and development.」

    R&D expenses for the current fiscal year were ¥194.023 million. The company is conducting R&D on video and 3D data for Impulse, as well as an overhaul of Neuron's architecture and its intelligent functions.
Moved together

"Strengthening the sales structure, including sales processes and sales partners" moved the same way as this thread, in the same document, in 3 of its 16 moves.

3322★1234
  1. ★This thread
  2. 1Strengthening the sales structure, including sales processes and sales partners3×
  3. 2Expansion of Software Sales and Recurring Revenue3×
  4. 3Supporting digital transformation through AI implementation in corporate operations2×
  5. 4Securing and Developing Advanced Technology Talent2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Brains Technology yet. It last moved in the General Meetings of Shareholders of 2026-10-07: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Creation of New Products and Services Through R&D | Brains Technology,Inc. (4075) | Komori